UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 771

Sortiert nach

Mutant p53 gain-of-function in cancer

Cold Spring Harbor perspectives in biology, 2010-02, Vol.2 (2), p.a001107-a001107

2010

Volltextzugriff (PDF)

Evaluation of the economic feasibility for the recycling of construction and demolition waste in China—The case of Chongqing

Resources, conservation and recycling, 2010-04, Vol.54 (6), p.377-389

2010

Volltextzugriff (PDF)

A system dynamics model for evaluating the alternative of type in construction and demolition waste recycling center – The case of Chongqing, China

Resources, conservation and recycling, 2011-09, Vol.55 (11), p.933-944

2011

Volltextzugriff (PDF)

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

Genes & cancer, 2011-04, Vol.2 (4), p.466-474

2011

Volltextzugriff (PDF)

42: The mutant p53-cancer stem cells and drug resistance paradigm

European journal of cancer (1990), 2014-07, Vol.50, p.S11-S11

Rotter, V

2014

Volltextzugriff (PDF)

Battery related cobalt and REE flows in WEEE treatment

Waste management (Elmsford), 2015-11, Vol.45, p.298-305

2015

Volltextzugriff (PDF)

Oncogenic mutations of the p53 tumor suppressor : The demons of the guardian of the genome

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (24), p.6788-6793

2000

Volltextzugriff (PDF)

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

Cancer gene therapy, 2011-01, Vol.18 (1), p.2-11

2011

Volltextzugriff (PDF)

p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity

Cell death and differentiation, 2013-05, Vol.20 (5), p.774-783

2013

Volltextzugriff (PDF)

Transcription regulation by mutant p53

Oncogene, 2007-04, Vol.26 (15), p.2202-2211

2007

Volltextzugriff (PDF)

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice

Diabetologia, 2008-07, Vol.51 (7), p.1306-1316

2008

Volltextzugriff (PDF)

p53 is balancing development, differentiation and de-differentiation to assure cancer prevention

Carcinogenesis (New York), 2010-09, Vol.31 (9), p.1501-1508

2010

Volltextzugriff (PDF)

Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ

Cell death and differentiation, 2014-09, Vol.21 (9), p.1347-1349

2014

Volltextzugriff (PDF)

Regulation of AIF expression by p53

Cell death and differentiation, 2006-12, Vol.13 (12), p.2140-2149

2006

Volltextzugriff (PDF)

p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition

Cell death and differentiation, 2013-02, Vol.20 (2), p.312-320

2013

Volltextzugriff (PDF)

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

Diabetologia, 2005, Vol.48 (1), p.96-104

2005

Volltextzugriff (PDF)

Mutant p53 upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

Cell death and differentiation, 2011-02, Vol.18 (2), p.271-281

2011

Volltextzugriff (PDF)

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation

Cell death and differentiation, 2016-03, Vol.23 (3), p.509-520

2016

Volltextzugriff (PDF)

Mutant p53 modulates the signal of hepatocyte growth factor (HGF) to endow cancer cells with drug resistance

European journal of cancer (1990), 2016-07, Vol.61, p.S134-S134

2016

Volltextzugriff (PDF)

Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop

Cell death and differentiation, 2012-01, Vol.19 (1), p.180-183

2012

Volltextzugriff (PDF)

Can an iPS cell secure its genomic fidelity?

Cell death and differentiation, 2011-05, Vol.18 (5), p.743-744

2011

Volltextzugriff (PDF)

Eine nationale Umfrage über das Vorhandensein von krankenhausinternen Leitlinien zum klinischen Management nach intrauterinem Fruchttod

Geburtshilfe und Frauenheilkunde, 2020, Vol.80 (6)

2020

Volltextzugriff (PDF)

Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation

Oncogene, 2009-12, Vol.28 (50), p.4469-4479

2009

Volltextzugriff (PDF)

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele

Cell death and differentiation, 2014-09, Vol.21 (9), p.1419-1431

2014

Volltextzugriff (PDF)

Repression of the MSP MST-1 gene contributes to the antiapoptotic gain of function of mutant p53

Oncogene, 2006-01, Vol.25 (3), p.359-369

2006

Volltextzugriff (PDF)

1 – 25 von 771

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(713)
Mit Volltextzugriff
(673)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(522)
Life Sciences & Biomedicine
(407)
Humans
(341)
Female
(155)
Animals
(154)
Male
(150)
Biological And Medical Sciences
(133)
Mice
(110)
Genetics & Heredity
(93)
Middle Aged
(92)
Biochemistry & Molecular Biology
(85)
Cell Biology
(78)
Adult
(77)
Fundamental And Applied Biological Sciences. Psychology
(77)
Aged
(76)
Physical Sciences
(72)
Genome-Wide Association Study
(69)
Medical Sciences
(66)
Physics
(64)
Genomes
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Oncogene
(38)
Molecular And Cellular Biology
(15)
American Journal Of Human Genetics
(14)
Cell Death And Differentiation
(13)
Circulation
(12)
Diabetes
(12)
Nature Communications
(12)
Nature Genetics
(12)
Plos Genetics
(12)
Journal Of The American Society Of Nephrology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Mutant p53 gain-of-function in cancer

Evaluation of the economic feasibility for the recycling of construction and demolition waste in China—The case of Chongqing

A system dynamics model for evaluating the alternative of type in construction and demolition waste recycling center – The case of Chongqing, China

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

42: The mutant p53-cancer stem cells and drug resistance paradigm

Battery related cobalt and REE flows in WEEE treatment

Oncogenic mutations of the p53 tumor suppressor : The demons of the guardian of the genome

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity

Transcription regulation by mutant p53

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice

p53 is balancing development, differentiation and de-differentiation to assure cancer prevention

Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ

Regulation of AIF expression by p53

p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

Mutant p53 upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation

Mutant p53 modulates the signal of hepatocyte growth factor (HGF) to endow cancer cells with drug resistance

Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop

Can an iPS cell secure its genomic fidelity?

Eine nationale Umfrage über das Vorhandensein von krankenhausinternen Leitlinien zum klinischen Management nach intrauterinem Fruchttod

Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele

Repression of the MSP MST-1 gene contributes to the antiapoptotic gain of function of mutant p53

Suchergebnisse filtern